Restructuring events
European Restructuring Monitor (ERM)
The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
CSL, an Australian biopharmaceutical company, announced approximately 500 job cuts affecting its research and development (R&D) unit at its Marburg site in Hesse, Germany.
The job losses are linked to the company’s decision to gradually close its R&D activities at the site as part of a global strategic realignment, with the closure expected to be completed by the end of 2026. The positions affected are mainly permanent full-time white-collar jobs in research and development.
The exact measures for implementing the redundancies are still under discussion, with the company currently negotiating with the works council to find solutions for the affected employees. No details have been provided regarding indirect job losses, although impacts on related activities cannot be excluded. Employee representatives are involved in ongoing negotiations, while local authorities have strongly criticised the decision. The mayor of Marburg described the planned closure as a “serious blow” to the city and the wider region and indicated that support measures would be explored.
CSL operates a major site in Marburg employing around 3,000 people, making it the largest site within the group. Despite the planned closure of R&D, the company has announced plans to invest approximately €400 million in expanding its production activities at the site.
Eurofound (2025), CSL Innovation, Closure in Germany, factsheet number 204460, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/204460.